Journal of Agricultural and Food Chemistry · 2001 · 192 citations · 9 references
Life SciencesBiochemistryEnzymologyFood ChemistryProtein BiochemistryAmino Acid-derived Natural ProductsBlood Pressure ControlBlood Pressure ManagementCardiovascular PharmacologyEnzyme InhibitionPeptide AnalysisAngiotensin-converting Enzyme Inhibitory PeptidesAntihypertensive Drug TherapyAntihypertensive PharmacologyAntihypertensive TreatmentBlood PressurePurificationRenin-angiotensin-aldosterone System InhibitionSystolic Blood Pressure
It has been reported that soybean peptide fractions isolated from Korean fermented soybean paste exert angiotensin I converting enzyme (ACE) inhibitory activity in vitro. In this study, further purification and identification of the most active fraction inhibiting ACE activity were performed, and its antihypertensive activity in vivo was confirmed. Subsequently, a novel ACE inhibitory peptide was isolated by preparative HPLC. The amino acid sequence of the isolated peptide was identified as His-His-Leu (HHL) by Edman degradation. The IC(50) value of the HHL for ACE activity was 2.2 microg/mL in vitro. Moreover, the synthetic tripeptide HHL (spHHL) resulted in a significant decrease of ACE activity in the aorta and led to lowered systolic blood pressure (SBP) in spontaneously hypertensive (SH) rats compared to control. Triple injections of spHHL, 5 mg/kg of body weight/injection resulted in a significant decrease of SBP by 61 mmHg (p < 0.01) after the third injection. These results demonstrated that the ACE inhibitory peptide HHL derived from Korean fermented soybean paste exerted antihypertensive activity in vivo.
9
Marco Gobbetti, Pasquale Ferranti, E. Smacchi et al. · Applied and Environmental Microbiology · 2000 · 339 citations
Osamu Masuda, Yasunori Nakamura, Toshiaki Takano · Journal of Nutrition · 1996 · 264 citations · Full text